Prince Akwasi Mensah

Array ( [id] => 5924488 [patent_doc_number] => 20060241136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Pharmaceutical composition combining tenatoprazole and a histamine h2-receptor antagonist' [patent_app_type] => utility [patent_app_number] => 10/532114 [patent_app_country] => US [patent_app_date] => 2003-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2279 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20060241136.pdf [firstpage_image] =>[orig_patent_app_number] => 10532114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7306544 [patent_doc_number] => 20040116530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Tissue fibrosis inhibitors' [patent_app_type] => new [patent_app_number] => 10/474193 [patent_app_country] => US [patent_app_date] => 2003-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5649 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20040116530.pdf [firstpage_image] =>[orig_patent_app_number] => 10474193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 627106 [patent_doc_number] => 07135490 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-14 [patent_title] => 'Method for the treatment of glomerulonephritis' [patent_app_type] => utility [patent_app_number] => 10/676118 [patent_app_country] => US [patent_app_date] => 2003-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6318 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/135/07135490.pdf [firstpage_image] =>[orig_patent_app_number] => 10676118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7454401 [patent_doc_number] => 20040068013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-08 [patent_title] => 'Compounds and compositions for delivering active agents' [patent_app_type] => new [patent_app_number] => 10/677906 [patent_app_country] => US [patent_app_date] => 2003-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8336 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20040068013.pdf [firstpage_image] =>[orig_patent_app_number] => 10677906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7386664 [patent_doc_number] => 20040082597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Use of CRF antagonists and related compositions' [patent_app_type] => new [patent_app_number] => 10/676201 [patent_app_country] => US [patent_app_date] => 2003-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21606 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20040082597.pdf [firstpage_image] =>[orig_patent_app_number] => 10676201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 467911 [patent_doc_number] => 07235573 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-26 [patent_title] => 'Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors' [patent_app_type] => utility [patent_app_number] => 10/676727 [patent_app_country] => US [patent_app_date] => 2003-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 31 [patent_no_of_words] => 19953 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/235/07235573.pdf [firstpage_image] =>[orig_patent_app_number] => 10676727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7281412 [patent_doc_number] => 20040063789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Mono-and disubstituted 3-propyl gamma-aminobutyric acids' [patent_app_type] => new [patent_app_number] => 10/674192 [patent_app_country] => US [patent_app_date] => 2003-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32905 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063789.pdf [firstpage_image] =>[orig_patent_app_number] => 10674192 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7270407 [patent_doc_number] => 20040058925 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-25 [patent_title] => 'Method of treating fibromyalgia and other somatoform disorders' [patent_app_type] => new [patent_app_number] => 10/669611 [patent_app_country] => US [patent_app_date] => 2003-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9136 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20040058925.pdf [firstpage_image] =>[orig_patent_app_number] => 10669611 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7238956 [patent_doc_number] => 20040157840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Rifalazil compositions and therapeutic regimens' [patent_app_type] => new [patent_app_number] => 10/668792 [patent_app_country] => US [patent_app_date] => 2003-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10508 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20040157840.pdf [firstpage_image] =>[orig_patent_app_number] => 10668792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7127902 [patent_doc_number] => 20050059646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Use of 4-androstene-3,6,17-trione to elevate testosterone levels and the testosterone/estrogen ratio in males' [patent_app_type] => utility [patent_app_number] => 10/662594 [patent_app_country] => US [patent_app_date] => 2003-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1467 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059646.pdf [firstpage_image] =>[orig_patent_app_number] => 10662594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4629461 [patent_doc_number] => 08008349 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-30 [patent_title] => 'Stable pharmaceutical preparation comprising levothyroxine sodium, gelatin and fillers and which is free of organic solvent residues' [patent_app_type] => utility [patent_app_number] => 10/661588 [patent_app_country] => US [patent_app_date] => 2003-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1324 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/008/08008349.pdf [firstpage_image] =>[orig_patent_app_number] => 10661588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474766 [patent_doc_number] => 20040122107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Method of alleviating barometric-induced symptoms in airline passengers' [patent_app_type] => new [patent_app_number] => 10/662137 [patent_app_country] => US [patent_app_date] => 2003-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1254 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20040122107.pdf [firstpage_image] =>[orig_patent_app_number] => 10662137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7207487 [patent_doc_number] => 20040087596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Methods and kit for treating Parkinson\'s disease' [patent_app_type] => new [patent_app_number] => 10/660090 [patent_app_country] => US [patent_app_date] => 2003-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5142 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20040087596.pdf [firstpage_image] =>[orig_patent_app_number] => 10660090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 505322 [patent_doc_number] => 07202222 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-10 [patent_title] => 'Methods for treatment of obesity and effective fat loss promotion' [patent_app_type] => utility [patent_app_number] => 10/660256 [patent_app_country] => US [patent_app_date] => 2003-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8666 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/202/07202222.pdf [firstpage_image] =>[orig_patent_app_number] => 10660256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7453567 [patent_doc_number] => 20040067947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-08 [patent_title] => 'Method of preventing or treating atherosclerosis or restenosis' [patent_app_type] => new [patent_app_number] => 10/651221 [patent_app_country] => US [patent_app_date] => 2003-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13292 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20040067947.pdf [firstpage_image] =>[orig_patent_app_number] => 10651221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7380401 [patent_doc_number] => 20040081693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Sustained release composition for oral administration of drugs' [patent_app_type] => new [patent_app_number] => 10/650931 [patent_app_country] => US [patent_app_date] => 2003-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 3405 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20040081693.pdf [firstpage_image] =>[orig_patent_app_number] => 10650931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7207830 [patent_doc_number] => 20040087631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Methods of treating cancer with HDAC inhibitors' [patent_app_type] => new [patent_app_number] => 10/650025 [patent_app_country] => US [patent_app_date] => 2003-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 20263 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20040087631.pdf [firstpage_image] =>[orig_patent_app_number] => 10650025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5776306 [patent_doc_number] => 20060104946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Method for treating inflammatory bowel disease' [patent_app_type] => utility [patent_app_number] => 10/525271 [patent_app_country] => US [patent_app_date] => 2003-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2249 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20060104946.pdf [firstpage_image] =>[orig_patent_app_number] => 10525271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7398453 [patent_doc_number] => 20040039021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Pharmaceutical anti-inflammatory aerosol formulation' [patent_app_type] => new [patent_app_number] => 10/311556 [patent_app_country] => US [patent_app_date] => 2003-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4041 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20040039021.pdf [firstpage_image] =>[orig_patent_app_number] => 10311556 [rel_patent_id] =>[rel_patent_doc_number] =>)